GlassScriptPhysician profile
Marius Calin
NPI 1568774222
$70,381.19
in general payments reported to CMS, 2019-2025
22 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,551 · 2020: $813 · 2021: $5,988 · 2022: $29K · 2023: $23K · 2024: $7,823 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Consulting Fee: $7,155 · Food and Beverage: $3,294 · Travel and Lodging: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,025.89 |
| Consulting Fee | $7,155.00 |
| Food and Beverage | $3,293.51 |
| Travel and Lodging | $657.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $55,047.41 | 2019-2023 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $9,257.31 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Bio-A Tissue Reinforcement |
| Medical Device Business Services, INC. | $1,775.32 | 2019 | |
| Ambu INC. | $1,169.72 | 2021-2025 | |
| Ethicon US, LLC | $879.00 | 2019-2023 | Echelon; Endopath, Vistaseal |
| Teleflex LLC | $570.95 | 2020-2023 | Titan Sgs Standard Gastric Stapler |
| Intra-Sana Laboratories | $357.26 | 2022-2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Boston Scientific Corporation | $317.70 | 2019 | |
| Tela Bio, INC. | $222.73 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $154.66 | 2021 | |
| Baxter Healthcare | $116.51 | 2023 | Floseal |
| Endogastric Solutions, INC | $110.43 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $86.78 | 2020-2024 | Gattex |
| Conmed Corporation | $68.20 | 2023-2024 | Airseal |
| Davol INC. | $64.82 | 2023 | Phasix Mesh |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $56.50 | 2022 | |
| Kerecis Limited | $42.11 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bayer Healthcare Pharmaceuticals INC. | $20.95 | 2019 | |
| Kci USA, INC. | $20.48 | 2023 | Prevena |
| Pacira Pharmaceuticals Incorporated | $14.89 | 2019 | |
| Shire North American Group INC | $13.99 | 2019 | |
| Endo Pharmaceuticals INC. | $13.47 | 2023 | Nascobal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marius Calin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.